4,496 Shares in Aflac Incorporated (NYSE:AFL) Bought by Yoffe Investment Management LLC

Yoffe Investment Management LLC bought a new stake in shares of Aflac Incorporated (NYSE:AFL - Free Report) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund bought 4,496 shares of the financial services provider's stock, valued at approximately $465,000.

Other hedge funds have also bought and sold shares of the company. Whipplewood Advisors LLC bought a new stake in Aflac during the fourth quarter valued at approximately $26,000. BankPlus Trust Department purchased a new position in shares of Aflac in the fourth quarter worth $34,000. Curio Wealth LLC purchased a new position in Aflac during the 4th quarter valued at $36,000. Capital A Wealth Management LLC bought a new stake in shares of Aflac during the 4th quarter valued at $38,000. Finally, OFI Invest Asset Management bought a new stake in shares of Aflac during the 4th quarter valued at $38,000. 67.44% of the stock is currently owned by institutional investors.

Aflac Price Performance

Shares of NYSE AFL traded up $0.68 during midday trading on Friday, reaching $103.49. 3,415,441 shares of the stock traded hands, compared to its average volume of 2,122,918. The company has a debt-to-equity ratio of 0.29, a current ratio of 0.10 and a quick ratio of 0.08. The stock has a market capitalization of $55.95 billion, a PE ratio of 10.78, a P/E/G ratio of 3.24 and a beta of 0.84. Aflac Incorporated has a one year low of $86.46 and a one year high of $115.50. The company's 50 day moving average is $106.15 and its 200 day moving average is $106.21.

Aflac (NYSE:AFL - Get Free Report) last issued its quarterly earnings results on Wednesday, April 30th. The financial services provider reported $1.66 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.67 by ($0.01). The company had revenue of $3.40 billion during the quarter, compared to the consensus estimate of $4.53 billion. Aflac had a return on equity of 16.20% and a net margin of 28.76%. The firm's quarterly revenue was down 37.5% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.66 earnings per share. On average, equities research analysts anticipate that Aflac Incorporated will post 6.88 earnings per share for the current year.

Aflac Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Monday, June 2nd. Stockholders of record on Wednesday, May 21st will be paid a dividend of $0.58 per share. The ex-dividend date is Wednesday, May 21st. This represents a $2.32 annualized dividend and a dividend yield of 2.24%. Aflac's dividend payout ratio is currently 36.25%.

Wall Street Analysts Forecast Growth

AFL has been the subject of a number of recent analyst reports. Raymond James decreased their target price on Aflac from $115.00 to $110.00 and set an "outperform" rating for the company in a research report on Thursday. Wells Fargo & Company upped their price target on shares of Aflac from $102.00 to $103.00 and gave the company an "equal weight" rating in a research report on Tuesday, May 6th. Barclays upped their price target on shares of Aflac from $95.00 to $96.00 and gave the company an "underweight" rating in a research report on Thursday, May 1st. Morgan Stanley upped their price target on shares of Aflac from $100.00 to $105.00 and gave the company an "equal weight" rating in a research report on Monday, May 19th. Finally, Keefe, Bruyette & Woods increased their target price on shares of Aflac from $104.00 to $106.00 and gave the stock a "market perform" rating in a report on Wednesday, May 7th. Three investment analysts have rated the stock with a sell rating, ten have issued a hold rating and three have assigned a buy rating to the stock. According to MarketBeat, Aflac presently has a consensus rating of "Hold" and an average target price of $104.93.

Insider Activity

In other news, Director Charles D. Lake II sold 29,802 shares of the business's stock in a transaction dated Monday, March 10th. The stock was sold at an average price of $107.29, for a total transaction of $3,197,456.58. Following the sale, the director now owns 49,962 shares in the company, valued at approximately $5,360,422.98. The trade was a 37.36% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Joseph L. Moskowitz sold 1,000 shares of the business's stock in a transaction dated Friday, March 7th. The stock was sold at an average price of $107.63, for a total value of $107,630.00. Following the sale, the director now owns 25,393 shares in the company, valued at $2,733,048.59. The trade was a 3.79% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 71,552 shares of company stock worth $7,609,382. Company insiders own 0.80% of the company's stock.

Aflac Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.